Product Images Aripiprazole

This text seems to be a table showing the effect of certain drugs on aripiprazole, including their CYP inhibitors, gastric acid blockers, and other drugs, as well as the fold change and 90% CI of aripiprazole. It is difficult to interpret the table without additional information or context.*

This is a list of drugs and their possible effects on aripiprazole, a medication used to treat schizophrenia and bipolar disorder. The list includes drugs that may inhibit or induce the activity of enzymes in the liver (CYpas) that are involved in the metabolism of aripiprazole, as well as drugs that may affect gastric acid levels. The provided image shows a graph displaying the fold change and percentage of change relative to a reference value without the interacting drugs.*

This text provides information on the effect of aripiprazole on other drugs, specifically on their metabolic pathways. The CYP2D6 B enzyme and drugs such as dextromethorphan, warfarin, omeprazole, and escitalopram are mentioned, as well as UGT1A4 and other drugs. The text also includes a fold change and 90% I graph showing the change relative to the reference without interacting drugs. No further information is available.*

This appears to be a table showing various factors that can impact the pharmacokinetics (PK) of a drug, such as age, gender, hepatic impairment, and renal impairment. It also shows the Avipiprazole Fold Change and 90% CI, which may be relevant for drug development and dosing calculations.*

This is a report on patient demographics including gender, age, and medical conditions such as Hepatic and Renal impairments. Additionally, there is a chart showing the Denyaro-Aripiprazole Fold Change and 90% CI relative to a reference value.*

This appears to be a graph showing a comparison of the relapse rate between two groups - one taking Avipiprazole and the other taking a placebo. The x-axis represents the days from randomization and the y-axis represents the proportion with relapse. However, the graph is not readable as some of the characters are missing or distorted, especially in the y-axis.*

This text appears to show a clinical trial comparing the effects of the drug Aripiprazole with a placebo in preventing relapse in a group of subjects. The data is presented in a graph, showing a proportion of subjects experiencing relapse over time, as well as a table of the number of subjects at risk in each group. The text provides no further details on the trial, outcome measures or populations, and is not sufficient to draw any definitive conclusions about the efficacy of Aripiprazole.*

This is a packaging label for Abilify 30mg Tablet by Amneal Pharmaceuticals. It includes information such as the expiration date, NDC number, and storage instructions. The label also reminds users to keep all drugs out of reach of children.*